Allen Chao logo

Allen Chao

Asia, T'ai-pei, Taiwan

Description

Dr. Chao was a co-founder of Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, serving as a director from 1985 to May 2008, ...

Investor Profile

Allen Chao has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series B (50%)

Country Focus

  • United States (50%)
  • Taiwan (50%)

Industry Focus

  • Biotechnology
  • Medical
  • Artificial Intelligence (Ai)
  • Biopharma
  • Health Care
  • Health Diagnostics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Allen Chao frequently co-invest with?

China Development Industrial Bank (CDIB)
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Co-Investments: 1
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 1
MedStar Health
North America, Maryland, United States, Columbia
Co-Investments: 1
Liquid 2 Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Milestone Capital China
Asia, Shanghai, China, Shanghai
Co-Investments: 1
AME Cloud Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Biomark Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
BoxGroup
North America, New York, United States, New York
Co-Investments: 1
Lerner Enterprises
North America, Maryland, United States, Rockville
Co-Investments: 1

What are some of recent deals done by Allen Chao?

Zephyr AI

Fairfax Station, Virginia, United States

Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.

Artificial Intelligence (AI)BiotechnologyMedical
SeedMar 30, 2022
Amount Raised: $18,500,000
Eden Biologics

Hsinchu, T'ai-wan, Taiwan

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical
Series BJun 19, 2014
Amount Raised: $35,000,000